| 0 | 💬 0 |
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
(nejm.org)
|
New England Journal of Medicine 2026-07-09 | #lung cancer #targeted therapy #alk-inhibitor #adjuvant #clinical trial |